Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal indomethacin for prevention of post-ERCP pancreatitis
ACTRN12613000096752Phase 4Not yet recruiting
- Sponsor
- Vinh-An Phan
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Vinh-An Phan. Primary endpoint: Post-ERCP pancreatitis. Planned start Feb 2013; status: not yet recruiting.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on ACTRN12613000096752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000096752.